Precision Oncology: New Tests Look Beyond Genes
Two new precision medicine tests, born out of research from the Califano Lab, have just received New York State Department of Health approval and are available to oncologists and cancer researchers for the front lines of patient care.
Symposium Spotlights Advancements in Translational Cancer Research
The recent Cancer Genomics Symposium featured talks by leading computational biologists, physicists, engineers, mathematicians, and oncologists, and explored important research grounded in cancer genomics and mathematical data analysis.
Novel Precision Medicine Trial for Metastatic Pancreatic Cancer
Herbert Irving Comprehensive Cancer Center and Systems Biology have been awarded a three-year grant from the Lustgarten Foundation to test a new precision medicine approach aimed at metastatic pancreatic cancer.
Identifying Effective Therapies for Gastric and Esophageal Cancers
Thanks to a four-year gift by the Price Family Foundation, a new research collaboration is underway between Columbia and the Broad Institute to accelerate the discovery of new cancer drug combinations targeted at gastric and esophageal cancer.
PLATE-Seq to Advance Personalized Cancer Treatment
Drug screening and analysis is critical in advancing research of cancer therapeutics. To this end, a Systems Biology-led team has developed PLATE-Seq, a new technique for low-cost, bulk mRNA sequencing. Coupled with genome-wide regulatory network analysis, the new method advances the goal of providing personalized treatment to patients.